IVD and gastric cancer: However, when IVD activity is compromised (e.g., due to genetic defects or mitochondrial dysfunction), isovaleryl-CoA accumulates and is diverted toward conjugation with carnitine, forming isovalerylcarnitine (C5) (Dimou et al, 2022), which we identify as a novel tumor suppressor in GC.